282 related articles for article (PubMed ID: 15857879)
21. Once daily aminoglycoside therapy. Is it less toxic than multiple daily doses and how should it be monitored?
Barclay ML; Kirkpatrick CM; Begg EJ
Clin Pharmacokinet; 1999 Feb; 36(2):89-98. PubMed ID: 10092956
[TBL] [Abstract][Full Text] [Related]
22. Once-daily dosing of aminoglycosides: review and recommendations for clinical practice.
Freeman CD; Nicolau DP; Belliveau PP; Nightingale CH
J Antimicrob Chemother; 1997 Jun; 39(6):677-86. PubMed ID: 9222035
[TBL] [Abstract][Full Text] [Related]
23. Pharmacokinetic outcomes of a simplified, weight-based, extended-interval gentamicin dosing protocol in critically ill neonates.
Hoff DS; Wilcox RA; Tollefson LM; Lipnik PG; Commers AR; Liu M
Pharmacotherapy; 2009 Nov; 29(11):1297-305. PubMed ID: 19857147
[TBL] [Abstract][Full Text] [Related]
24. Once-daily aminoglycoside dosing: An update on current literature.
Stankowicz MS; Ibrahim J; Brown DL
Am J Health Syst Pharm; 2015 Aug; 72(16):1357-64. PubMed ID: 26246292
[TBL] [Abstract][Full Text] [Related]
25. Quantitative Analysis of Gentamicin Exposure in Neonates and Infants Calls into Question Its Current Dosing Recommendations.
van Donge T; Pfister M; Bielicki J; Csajka C; Rodieux F; van den Anker J; Fuchs A
Antimicrob Agents Chemother; 2018 Apr; 62(4):. PubMed ID: 29358294
[TBL] [Abstract][Full Text] [Related]
26. Pharmacological considerations for the proper clinical use of aminoglycosides.
Pagkalis S; Mantadakis E; Mavros MN; Ammari C; Falagas ME
Drugs; 2011 Dec; 71(17):2277-94. PubMed ID: 22085385
[TBL] [Abstract][Full Text] [Related]
27. β-lactam antibiotic versus combined β-lactam antibiotics and single daily dosing regimens of aminoglycosides for treating serious infections: A meta-analysis.
Heffernan AJ; Sime FB; Sun J; Lipman J; Kumar A; Andrews K; Ellwood D; Grimwood K; Roberts J
Int J Antimicrob Agents; 2020 Mar; 55(3):105839. PubMed ID: 31704215
[TBL] [Abstract][Full Text] [Related]
28. Prospective evaluation of the effect of an aminoglycoside dosing regimen on rates of observed nephrotoxicity and ototoxicity.
Rybak MJ; Abate BJ; Kang SL; Ruffing MJ; Lerner SA; Drusano GL
Antimicrob Agents Chemother; 1999 Jul; 43(7):1549-55. PubMed ID: 10390201
[TBL] [Abstract][Full Text] [Related]
29. Extended-interval dosing of tobramycin in neonates: implications for therapeutic drug monitoring.
de Hoog M; Mouton JW; Schoemaker RC; Verduin CM; van den Anker JN
Clin Pharmacol Ther; 2002 May; 71(5):349-58. PubMed ID: 12011820
[TBL] [Abstract][Full Text] [Related]
30. Exploration of once-daily dosing of aminoglycosides through Bayesian simulation.
Garrelts JC
Pharmacotherapy; 1996; 16(2):286-94. PubMed ID: 8820474
[TBL] [Abstract][Full Text] [Related]
31. The use of extended-interval aminoglycoside dosing strategies for the treatment of moderate-to-severe infections encountered in critically ill surgical patients.
Mueller EW; Boucher BA
Surg Infect (Larchmt); 2009 Dec; 10(6):563-70. PubMed ID: 20035611
[TBL] [Abstract][Full Text] [Related]
32. Preclinical and clinical evaluation of once-daily aminoglycoside chemotherapy.
Periti P
J Chemother; 1995 Aug; 7(4):311-37. PubMed ID: 8568543
[TBL] [Abstract][Full Text] [Related]
33. Single daily dosing of aminoglycosides in immunocompromised adults: a systematic review.
Hatala R; Dinh TT; Cook DJ
Clin Infect Dis; 1997 May; 24(5):810-5. PubMed ID: 9142773
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of vancomycin dosing regimens in preterm and term neonates using Monte Carlo simulations.
Mehrotra N; Tang L; Phelps SJ; Meibohm B
Pharmacotherapy; 2012 May; 32(5):408-19. PubMed ID: 22488303
[TBL] [Abstract][Full Text] [Related]
35. Aminoglycoside dosing in diabetes.
Axworthy S; Gardner D
J Clin Pharm Ther; 2000 Apr; 25(2):81-4. PubMed ID: 10849185
[TBL] [Abstract][Full Text] [Related]
36. Extended-Interval Dosing of Gentamicin Aiming for a Drug-Free Period in Neonates: A Prospective Cohort Study.
van Maarseveen EM; Sprij A; Touw DJ
Ther Drug Monit; 2016 Jun; 38(3):402-6. PubMed ID: 26836810
[TBL] [Abstract][Full Text] [Related]
37. Once daily aminoglycoside dosing: maintained efficacy with reduced nephrotoxicity?
Zhanel GG; Ariano RE
Ren Fail; 1992; 14(1):1-9. PubMed ID: 1561384
[TBL] [Abstract][Full Text] [Related]
38. Extended interval dosing of gentamicin in premature neonates ≤ 28-week gestation.
Alshaikh B; Dersch-Mills D; Taylor R; Akierman AR; Yusuf K
Acta Paediatr; 2012 Nov; 101(11):1134-9. PubMed ID: 22897142
[TBL] [Abstract][Full Text] [Related]
39. Tobramycin population pharmacokinetics in neonates.
de Hoog M; Schoemaker RC; Mouton JW; van den Anker JN
Clin Pharmacol Ther; 1997 Oct; 62(4):392-9. PubMed ID: 9357390
[TBL] [Abstract][Full Text] [Related]
40. The efficacy and toxicity of two dosing-regimens of amikacin in neonates with sepsis.
Abdel-Hady E; El Hamamsy M; Hedaya M; Awad H
J Clin Pharm Ther; 2011 Feb; 36(1):45-52. PubMed ID: 21198719
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
